|
STON2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.985000E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.177600E-03 |
| Normal-vs-Stage2 |
4.979000E-01 |
| Normal-vs-Stage3 |
9.318200E-01 |
| Normal-vs-Stage4 |
4.767600E-01 |
| Stage1-vs-Stage2 |
5.104200E-01 |
| Stage1-vs-Stage3 |
1.484040E-01 |
| Stage1-vs-Stage4 |
2.671800E-02 |
| Stage2-vs-Stage3 |
6.210200E-01 |
| Stage2-vs-Stage4 |
3.133400E-01 |
| Stage3-vs-Stage4 |
5.681600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.31020000004867E-06 |
| Normal-vs-AfricanAmerican |
1.775220E-01 |
| Normal-vs-Asian |
1.772830E-01 |
| Caucasian-vs-AfricanAmerican |
2.00070000000441E-06 |
| Caucasian-vs-Asian |
1.406200E-01 |
| AfricanAmerican-vs-Asian |
8.774600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.80340000000201E-05 |
| Normal-vs-Female |
5.723800E-01 |
| Male-vs-Female |
2.079800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.749600E-01 |
| Normal-vs-Extreme_Weight |
8.781100E-03 |
| Normal-vs-Obese |
3.453500E-02 |
| Normal-vs-Extreme_Obese |
9.630100E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.792100E-02 |
| Normal_Weight-vs-Obese |
1.138750E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.291960E-01 |
| Extreme_Weight-vs-Obese |
9.767200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.090200E-01 |
| Obese-vs-Extreme_Obese |
4.782600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.852200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.021590E-03 |
| Normal-vs-Age(61-80Yrs) |
7.439000E-03 |
| Normal-vs-Age(81-100Yrs) |
6.524000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.276600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.411600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.087800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.263200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.436900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.879600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.00230000252577E-08 |
| Normal-VS-Type2 PRCC |
5.035400E-01 |
| Normal-VS-KIRP CIMP |
1.979690E-04 |
| Normal-VS-Unclassified PRCC |
1.483250E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.78762999999416E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.55350999999637E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
2.378600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.528300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.489800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.123500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.663600E-02 |
| Normal-vs-N1 |
3.778000E-01 |
| Normal-vs-N2 |
8.586800E-04 |
| N0-vs-N1 |
6.218400E-01 |
| N0-vs-N2 |
7.290000E-02 |
| N1-vs-N2 |
1.467570E-01 |
|
|
